3.Applied in pharmaceutical field.it can treat various dieases
The American Diabetes Association (ADA) recognizes the cardiovascular benefits of GLP-1 receptor agonists in their Standards of Care but does not currently recommend these agents solely for inflammation management outside established indications for diabetes, obesity, or cardiovascular risk reduction
Exercising, staying hydrated, and healthy diets help fuel our bodies, brain, and mental wellbeing
These factors collectively determine whether what you inject matches what the label says it contains
1 However, it is recommended to avoid use in patients with a personal or family history of MTC and in patients with multiple neoplasia syndrome type 2
In summary, the new method of cycloalka[ b ]indole library construction reported here has identified JWU-A021 to be a GLP-1 secretagogue with potent TRPA1 activating properties, not only in STC-1 cells, but also in mouse L-cells